Hepatitis B virus (HBV) infection continues to be a major public health issue worldwide.
HBsAg loss is associated with functional remission and improved long‐term outcome, and is …

Autoimmune hemolytic anemia (AIHA) is an acquired, heterogeneous group of diseases
which includes warm AIHA, cold agglutinin disease (CAD), mixed AIHA, paroxysmal cold …

Objectives: Tocilizumab (TCZ), an IL-6 receptor antagonist, is used in the treatment of severe
COVID-19 caused by infection with SARS-CoV-2. However, unintended consequences of …

Chronic hepatitis B (CHB) remains a global healthcare burden. Although the recent
developments in the field have led to a reduction in incidence, the morbidity and mortality …

Hepatitis B surface antigen (HBsAg) loss is an ideal treatment endpoint for patients with
chronic hepatitis B (CHB). We investigated the predictive value of on-treatment HBsAg levels …

Simple Summary This review analyzes the occurrence, clinical characteristics, and
prognostic impact and treatment of autoimmune hemolytic anemia (AIHA) in chronic …

Rheumatoid arthritis (RA) affects around 1.2% of the adult population. RA is one of the main
reasons for work disability and premature retirement, thus substantially increasing social …

Hepatitis B virus (HBV) reactivation can lead to severe acute hepatic failure and death in
patients with HBV infection. HBV reactivation (HBVr) most commonly develops in patients …

Inflammatory bowel disease (IBD) is generally considered a disease of high-income
countries and is regarded as rare in sub-Saharan Africa. However, this assumption is almost …

The natural history of occult hepatitis B virus infection (OBI) and the mechanism involved in
HBV reactivation are only partially understood. As regards people living with HIV (PLWH) …